Is Direct Meds legit and worth it?
Direct Meds is a real GLP-1 telehealth provider; we read its site and scored it 4.0/5 in our independent review (Strong Choice). It is best for patients who want a trustworthy, quality-verified compounded GLP-1 provider at an affordable price and are comfortable managing nutritional changes on their own. Biggest plus: Lab testing included. Watch-out: No dietitian access.
Scorecard: strongest in Reputation (4.8/5) and Access (4.7/5); weakest in Support (3.0/5) and Patient Protection (3.4/5).
Medications
Semaglutide, Tirzepatide (as entered 10 April 2026; capture date not recorded); Oral semaglutide, oral tirzepatide (oral, seen on its site 7 October 2026)
Monthly Cost
$80 to $300 (as entered 10 April 2026; capture date not recorded)
Speed to Start
Fast
Prices and medications in this review are as entered in our research on 10 April 2026 (the date we captured them was not recorded), unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
Est. 2024
About Direct Meds
Direct Meds has rapidly established itself as one of the most popular GLP-1 telehealth providers since its founding in 2024. The numbers speak volumes: with over 8,650 reviews on Trustpilot and a 4.6-star rating, Direct Meds has amassed one of the largest and most positive review profiles in the entire compounded GLP-1 market. The platform offers compounded semaglutide and compounded tirzepatide at prices ranging from $80 to $300 per month, with entry-level pricing that undercuts the majority of its competitors.
Direct Meds says its medications undergo third-party testing for purity, safety and potency; it publishes no certificate of analysis, and we have not verified the testing claim. Direct Meds includes lab testing as part of its program — a clinical feature that many competitors at similar price points do not offer.
The Trustpilot profile for Direct Meds is among the most robust we have reviewed. A 4.6-star rating across 8,650+ reviews is not only impressive in absolute terms but also demonstrates remarkable consistency at scale. Maintaining a high rating as review volume grows is significantly harder than earning high marks from a handful of early adopters, and this sustained performance suggests that Direct Meds delivers a reliably positive patient experience across a very large customer base.
The platform does have some limitations worth noting. Direct Meds does not offer dietitian access or structured nutritional support, which means patients looking for a holistic weight management program will need to supplement their medication with external resources. Insurance is not accepted, so all costs are out-of-pocket.
For patients seeking compounded GLP-1 medications with strong quality assurance, competitive pricing, and the confidence that comes from thousands of positive patient reviews, Direct Meds is one of the strongest options available. The combination of included lab testing, aggressive pricing, and an exceptional Trustpilot track record makes this a high-trust provider that earns a top-tier score from our editorial team. The only factors preventing a higher rating are the lack of dietitian support and the absence of insurance options.
Direct Meds GLP-1 Medications
Screenshot of Direct Meds, captured by 10 April 2026
Screenshot of Direct Meds, captured by 10 April 2026
Screenshot of Direct Meds, captured by 10 April 2026
Screenshot of Direct Meds, captured by 10 April 2026
Screenshot of Direct Meds, captured by 10 April 2026
At a Glance
Medications Offered
Semaglutide, Tirzepatide (as entered 10 April 2026; capture date not recorded); Oral semaglutide, oral tirzepatide (oral, seen on its site 7 October 2026)
Compounded
Cost & Insurance
- Monthly: $80 to $300 (as entered 10 April 2026; capture date not recorded)
- 6-month estimate: $480 – $1800 (as entered 10 April 2026; capture date not recorded)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: Yes
- Dietitian access: No
- Pharmacies named: Licensed U.S. compounding pharmacies (as described by Direct Meds); third-party testing claimed, not independently verified, and no certificate of analysis published; specific names not disclosed
Delivery & Access
- Format: Both (Oral and Subcutaneous)
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not stated Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown.
What the Direct Meds Intake Looks Like
We walked through Direct Meds’ full GLP-1 intake ourselves, from the first BMI screen through the 31-step questionnaire to the 90-day starter-pack checkout. Here’s what an actual prospective patient encounters before being prescribed.
/ 10
Direct Meds is the only compounded provider in our catalog to ask for an actual blood-pressure RANGE and a resting heart-rate range, both with AHA-aligned categories. Two long safety multi-selects cover suicidal thoughts, eating disorders, MTC + MEN2 family history, and a sex-specific symptom screen. Knocked down by no validated PHQ, no dedicated eating-disorder screen, no substance/alcohol screen, and a free-text-free meds review.
/ 10
Moderate. Thirty-one numbered question screens plus four marketing/testimonial interstitials inflate the screen count, and an ID-upload acknowledgment is required at checkout. Email and phone are collected late (Eligibility stage), so there’s no early account gate, but the 90-day starter pack and the optional $49.95 “front of the line” upsell add commercial pressure at the end.
The 5 Stages
Clinical Safety Screens Performed
The intake doesn’t use a validated PHQ-2 or PHQ-9 depression screen — suicidal thoughts is one item in a 12-option multi-select rather than a dedicated question. Eating disorders are checkbox items in the same multi-select rather than a dedicated screen with severity grading. There is no substance or alcohol screen, no general drug or food allergy screen, and no actual medication list — only a Yes/No on whether the patient currently takes medications. Diet and exercise are asked as a willingness-to-change gate, not as current-history questions. Sex is collected as a binary Male/Female only, with no separate gender identity question.
Most compounded GLP-1 providers either skip blood pressure entirely or include it as a single checkbox in a comorbidity list. Direct Meds asks the patient to pick a BP range aligned with AHA staging — Normal (<120/80), Elevated (120–129/<80), High Stage 1 (130–139/80–89), High Stage 2 (≥140/90), or Not sure — and a resting heart-rate range on a similar scale. Combined with a sleep quality + duration block, this is meaningfully closer to a primary-care intake than the typical compounded-only flow. The trade-off: it’s a self-reported range, not a measured value.
Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the Direct Meds weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens directmeds.com in a new tab.
Corrected 9 October 2026. This review said Direct Meds provides certificate-of-analysis (CoA) testing and listed “CoA provided” and “CoA testing verified” among its strengths. That was our error. Direct Meds says its medications undergo third-party testing for purity, safety and potency, but it publishes no certificate of analysis, and we had not verified the testing claim.
Start your GLP-1 weight loss journey with Direct Meds today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
